BMC medical imaging
Cure8 research brief
Why This Matters
People with Crohn’s disease can have liver involvement that may be missed on routine exams. Quantitative liver MRI measures (fat fraction and extracellular volume) could help detect and monitor subtle liver injury related to intestinal inflammation.
Who Should Pay Attention
Clinicians managing IBD patients, radiologists, researchers studying IBD‑related liver injury, and adult patients with Crohn’s disease concerned about extraintestinal liver complications.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study used liver MRI techniques (IDEAL-IQ for MRI-PDFF and T1 mapping with calculation of extracellular volume fraction, ECV) in a cohort of 107 treatment‑naive patients with Crohn’s disease to look for subclinical liver injury and correlations with clinical activity and blood/stool markers.
The authors report that MRI‑PDFF and ECV varied with levels of intestinal inflammation and showed statistically significant differences across activity groups; they evaluated correlations with serologic markers (ALT, AST, ALP, GGT, ESR) and fecal calprotectin and used ROC curves to compare diagnostic performance.
The paper concludes that chronic systemic inflammation in CD may cause liver involvement that can be detected by these quantitative MRI measures even when not visually apparent on routine imaging. This brief is grounded in the article abstract provided by the journal (structured content depth: abstract).
It summarizes the study design and main conclusions as stated by the authors without implying clinical recommendations or additional results beyond the abstract.
Keep In Mind
This report is a retrospective clinical study summarized in the article abstract; it describes associations rather than proving causation. The findings are preliminary and come from a single study population of treatment‑naive patients; further validation and prospective studies would be needed before changing clinical practice.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationBMC medical imaging
AuthorsZhu L, Zhang Z, Ma Y +5 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedJul 13, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Monitoring Crohn's Disease After Surgery with Fecal Calprotectin - Physician's Weekly
People with Crohn's disease who have an ileostomy need reliable, noninvasive tools to monitor for postoperative small-bowel inflammation. This study suggests fecal calprotectin measured from ileostomy output may help...
Faecal Calprotectin Predicts Inflammation in Crohn’s Disease
Faecal calprotectin from ileostomy output could provide a non-invasive way to detect small-bowel inflammation after surgery, helping to guide monitoring and reduce reliance on invasive tests for postoperative Crohn’s...
Evaluation of serum human galectin 3 as a marker of activity in inflammatory bowel disease in comparison to fecal calprotectin.
Noninvasive blood biomarkers that track IBD activity could reduce reliance on repeat endoscopy. If validated, serum galectin‑3 might complement fecal calprotectin and CRP to help identify active disease.